Alternatives to transfusion Flashcards
What are the risks of blood in clinical areas?
Serious Adverse Reactions Serious Adverse Events Sustainability of the blood supply Cost Immunomodulation
What is Immunomodulation?
A change in the body’s immune system, caused by agents that activate or suppress its function.
What and do bioactive lipids cause immunomodulation after or during transfusion?
Polyunsaturated fatty acids accumulate in blood units during storage and may play a role in inflammation and transfusion-related acute lung injury.
What and do extracellular vesciles cause immunomodulation after or during transfusion?
Tiny microvesicles, exosomes and other components increase during blood storage and may cause both inflammation and immunosuppression.
How do white blood cells cause immunomodulation ?
Most get removed during blood processing, but white cells and their components (such as cytokines) may increase infection, inflammation and immunosuppression risk.
How do red blood cells cause immunomoduation?
The influx of blood may tax the body’s monocytes and macrophages. This overload may trigger inflammation and immunpsupression by changing the balance of oxygen, iron and haemoglobin.
How does storage and processing of transfusion blood lead to immunomodulation?
Stored red blood cells develop storage lesions over time, impacting everything from pH to how cells use oxygen and itron.
How do platelets cause immunomodulation?
Microparticles derived from platelets can suppress or activate immune cells.
How does transfusion affect survival and why?
The more units of transfusion you have had, the lower the survival rate is expected to be.
This is thought to be because immunomodulation is caused by transfusion.
Write what is on the patient blood management scheme in terms of a transfusion?
It is important to discuss the risks, benefits and alternatives with patients in order to gain informed consent.
Inappropriate use of transfusion must be avoided.
What is the patient blood management scheme?
Evidence-based approach to optimise the care of patients who might need a blood transfusion.
What are the recommendations of the patient-blood management scheme?
Reducing number and frequency of blood tests.
Ensuring blood sample results are reliable.
Identify and treat anaemia prior to elective surgery.
Avoid transfusion if alternatives are available.
In what types of people is reducing the frequency of blood tests important and why?
For very young or old people and people with underlying health conditions such as anaemia. Frequent blood transfusions could negatively effect these people.
Why shouldn’t patients who are being given a drip not have blood samples taken?
This may dilute the sample and give fake results.
Why have we now moved on from not allowing 1 unit of blood to be given?
1 unit of blood was previously seen as a risk. However, we now know that 1 unit of blood can increase Hb sufficiently and allow patients to be discharged.
What is an autologous blood transfusion?
Collection and rein fusion of the patients own red blood cells.
Why is autologous blood rarely used?
There have been concerns about viral transmission of donor blood, especially during the HIV epidemic.
What is acute normovolemic haemodilution and when is it performed?
It is performed immediately before surgery and involves the removal of whole blood from a patients and replacement of circulating blood volume with collid and or crystalloid solutions.
What is contained within the blood of acute normovolemic haemodilutions?
Functional platelets and clotting factors
What is the overall purpose of acute normovolemic haemodilution?
Minimises red cell loss overall during the transfusion.
In what type of patients is acute normovolemic haemoldilution used?
- Used in adult patients undergoing surgery in which substantial blood loss is anticipated - this will minimise the blood they use.
- Also used in patients wh refuse donor blood such as Jehovas’ witnesses.
Is acute normovolemic haemodilution used alone?
It can be used alone or in combination with other patient blood management strategies.
What people shouldn’t be given normovolemic haemodilution and why?
People with anaemia because they won’t have sufficient red cells to support the procedure.
People who have had renal failure or significant heart disease as these issues could be exacerbated.